Remove 2015 Remove Documentation Remove Packaging Remove Pharmaceutical Companies
article thumbnail

Agile, Data-Driven Life Cycle Management for Continuous Manufacturing

ISPE

1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. An average of two approved drugs via CM per year since 2015 shows that progress has been slow but steady and that interest in CM and its potential has been sustained.

article thumbnail

Sustainability: Corporate Ambition, Governance, & Accelerated Delivery

ISPE

October 2015. A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. Department of Economic and Social Affairs: Sustainable Development.